User requirements
This codelist aims to identify the prescribing of semaglutide products which are licenced for the treatment of obesity.
Coding system
dm+d
Search terms / synonyms / search strategy
Search strategy
Semaglutide AMPs under dm+d category Semaglutide (VTM) 777514008 were reviewed and considered for inclusion.
Licencing information was interpreted from the relevant Summary of Product Characteristics (SPC):
Obesity
Diabetes
If all of the AMPs under a VMP related to the same indication, then the VMP code was also considered for inclusion in the codelist. If the VMP code contained AMPs which had different indications, then the VMP code was excluded.
This led to Semaglutide 0.5mg/0.37ml solution for injection 1.5ml pre-filled disposable devices (VMP) 36491011000001101 being excluded. This code has a count of 1285 prescriptions for August 2025, which is approximately 1% of all dispensed semaglutide, or 14% of dispensed semaglutide which is beneath that VMP. So, although this does reduce the sensitivity of this codelist, the impact is relatively small.
Inclusion criteria for codes
Codes which:
- refer to a product that contains semaglutide and,
- where the product is licensed exclusively for the treatment of obesity.
Exclusion criteria for codes
Codes which:
- do not refer to a product that contains semaglutide or,
- where the product is not licensed exclusively for the treatment of obesity.
Borderline cases
None identified.
Final codelist
https://www.opencodelists.org/codelist/opensafely/semaglutide-for-obesity/2bcfc7fe/
User requirements
This codelist aims to identify the prescribing of semaglutide products which are licenced for the treatment of obesity.
Coding system
dm+d
Search terms / synonyms / search strategy
Search strategy
Semaglutide AMPs under dm+d category
Semaglutide (VTM) 777514008were reviewed and considered for inclusion.Licencing information was interpreted from the relevant Summary of Product Characteristics (SPC):
Obesity
Diabetes
If all of the AMPs under a VMP related to the same indication, then the VMP code was also considered for inclusion in the codelist. If the VMP code contained AMPs which had different indications, then the VMP code was excluded.
This led to
Semaglutide 0.5mg/0.37ml solution for injection 1.5ml pre-filled disposable devices (VMP) 36491011000001101being excluded. This code has a count of 1285 prescriptions for August 2025, which is approximately 1% of all dispensed semaglutide, or 14% of dispensed semaglutide which is beneath that VMP. So, although this does reduce the sensitivity of this codelist, the impact is relatively small.Inclusion criteria for codes
Codes which:
Exclusion criteria for codes
Codes which:
Borderline cases
None identified.
Final codelist
https://www.opencodelists.org/codelist/opensafely/semaglutide-for-obesity/2bcfc7fe/